Publications by authors named "Simone Seyringer"

Claim this Profile
V
Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.
Micha J Pilz, Simone Seyringer, Virginie Nerich, Madeleine T King, Richard Norman

Pharmacoeconomics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma.
Simone Seyringer, Micha J Pilz, Andrew Bottomley, Madeleine T King, Richard Norman

Eur J Health Econ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical issues with methods and results interpretation at validating the EQ-5D-5L and QLU-C10D utilities in gastric cancer patients : Referring to: Pan, C. W., he, J. Y., Zhu, Y. B., Zhao, C. H., Luo, N., & Wang, P.: Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. The European journal of health economics, 24(6), 885-893 (2003).
Simone Seyringer, Eva Maria Gamper

Eur J Health Econ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets.
Simone Seyringer, Micha J Pilz, Imad Al-Naesan, Madeleine T King, Andrew Bottomley

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence" [Eur J Cancer (2025) 115235].
Simone Seyringer, Micha Pilz, Femke Jansen, Matthias Büttner, Madeleine T King

Eur J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence.
Simone Seyringer, Micha Johannes Pilz, Femke Jansen, Matthias Büttner, Madeleine T King

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
Micha J Pilz, Simone Seyringer, Susanne Singer, Georgios Ioannidis, Gerasimos P Sykiotis

Thyroid· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.
Micha J Pilz, Simone Seyringer, Imad Al-Naesan, Madeleine T King, Andrew Bottomley

Pharmacoecon Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bottom Up Ethics - Neuroenhancement in Education and Employment.
Imre Bard, George Gaskell, Agnes Allansdottir, Rui Vieira da Cunha, Peter Eduard, Simone Seyringer

Neuroethics· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public views on gene editing and its uses.
George Gaskell, Imre Bard, Agnes Allansdottir, Rui Vieira da Cunha, Peter Eduard, Simone Seyringer

Nat Biotechnol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis